Maternal molecular hydrogen treatment attenuates lipopolysaccharide-induced rat fetal lung injury

Free Radical Research

Volumn 49, Issue 8, 2015, Pages 1026-1037

  Hattori, Y ^a   Kotani, Tomomi ^a   Tsuda, H ^a   Mano, Y ^a   Tu, L ^b   Li, H ^a   Hirako, S ^a   Ushida, T ^a   Imai, K ^a   Nakano, T ^a   Sato, Y ^c   Miki, R ^b   Sumigama, S ^a   Iwase, A ^a   Toyokuni, S ^a   Kikkawa, F ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Bio database Institute of Reproductive and Developmental Medicine   (Japan)

^c NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

IL 6; lipopolysaccharide; lung; reactive oxygen species

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CASPASE 3; CASPASE 7; GELATINASE B; HYDROGEN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PHOSPHATE BUFFERED SALINE; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN A; ANTIINFLAMMATORY AGENT;

A549 CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG MECHANISM; ENVIRONMENTAL EXPOSURE; FEMALE; FETUS; FETUS LUNG; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG INJURY; NEWBORN; NONHUMAN; OXIDATIVE STRESS; RAT; ANIMAL; BRONCHOPULMONARY DYSPLASIA; DRUG EFFECTS; FETOMATERNAL TRANSFUSION; GENE EXPRESSION; GENETICS; IMMUNOLOGY; LUNG; METABOLISM; PATHOLOGY; PREGNANCY; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION; TUMOR CELL LINE;

RATTUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BRONCHOPULMONARY DYSPLASIA; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION; HUMANS; HYDROGEN; LIPOPOLYSACCHARIDES; LUNG; MATERNAL-FETAL EXCHANGE; MATRIX METALLOPROTEINASE 9; PREGNANCY; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84938357273     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2015.1038257     Document Type: Article

References (37)

1. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012;379:2162-2172.
2. Costeloe KL, Hennessy EM, Haider S, Stacey F, Marlow N, Draper ES. Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies). BMJ 2012;345:e7976.
3. Sorokin Y, Romero R, Mele L, Wapner RJ, Iams JD, Dudley DJ, et al. Maternal serum interleukin-6, C-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth < 32 weeks and adverse neonatal outcomes. Am J Perinatol 2010;27:631-640.
4. Zanardo V, Vedovato S, Cosmi E, Litta P, Cavallin F, Trevisanuto D, Chiarelli S. Preterm premature rupture of membranes, chorioamnion inflammatory scores and neonatal respiratory outcome. BJOG 2010;117:94-98.
5. Kramer BW. Antenatal inflammation and lung injury: prenatal origin of neonatal disease. J Perinatol 2008;A28 Suppl 1: S21-27.
6. Hofer N, Kothari R, Morris N, Muller W, Resch B. The fetal inflammatory response syndrome is a risk factor for morbidity in preterm neonates. Am J Obstet Gynecol 2013;209:542 e541-542 e511.
7. Kim SK, Romero R, Chaiworapongsa T, Kusanovic JP, Mazaki-Tovi S, Mittal P, et al. Evidence of changes in the immunophenotype and metabolic characteristics (intracellular reactive oxygen radicals) of fetal, but not maternal, monocytes and granulocytes in the fetal inflammatory response syndrome. J Perinat Med 2009;37:543-552.
8. Kawamura T, Wakabayashi N, Shigemura N, Huang CS, Masutani K, Tanaka Y, et al. Hydrogen gas reduces hyperoxic lung injury via the Nrf2 pathway in vivo. Am J Physiol Lung Cell Mol Physiol 2013;304:L646-656.
9. Terasaki Y, Ohsawa I, Terasaki M, Takahashi M, Kunugi S, Dedong K, et al. Hydrogen therapy attenuates irradiation-induced lung damage by reducing oxidative stress. Am J Physiol Lung Cell Mol Physiol 2011;301:L415-426.
10. Xie K, Yu Y, Huang Y, Zheng L, Li J, Chen H, et al. Molecular hydrogen ameliorates lipopolysaccharide-induced acute lung injury in mice through reducing inflammation and apoptosis. Shock 2012;37:548-555.
11. Mano Y, Kotani T, Ito M, Nagai T, Ichinohashi Y, Yamada K, et al. Maternal molecular hydrogen administration ameliorates rat fetal hippocampal damage caused by in utero ischemia-reperfusion. Free Radic Biol Med 2014;69:324-330.
12. Nakashima-Kamimura N, Mori T, Ohsawa I, Asoh S, Ohta S. Molecular hydrogen alleviates nephrotoxicity induced by an anticancer drug cisplatin without compromising anti-tumor activity in mice. Cancer Chemother Pharmacol 2009;64:753-761.
13. Itoh T, Hamada N, Terazawa R, Ito M, Ohno K, Ichihara M, et al. Molecular hydrogen inhibits lipopolysaccharide/interferon gamma-induced nitric oxide production through modulation of signal transduction in macrophages. Biochem Biophys Res Commun 2011;411:143-149.
14. Parajuli B, Sonobe Y, Horiuchi H, Takeuchi H, Mizuno T, Suzumura A. Oligomeric amyloid beta induces IL-1beta processing via production of ROS: implication in Alzheimer ' s disease. Cell Death Dis 2013;4:e975.
15. Cao L, Wang J, Tseu I, Luo D, Post M. Maternal exposure to endotoxin delays alveolarization during postnatal rat lung development. Am J Physiol Lung Cell Mol Physiol 2009;296:L726-737.
16. Nogueira-Silva C, Carvalho-Dias E, Piairo P, Nunes S, Baptista MJ, Moura RS, et al. Local fetal lung renin-angiotensin system as a target to treat congenital diaphragmatic hernia. Mol Med 2012;18:231-243.
17. Toyokuni S, Tanaka T, Hattori Y, Nishiyama Y, Yoshida A, Uchida K, et al. Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 1997;76:365-374.
18. Cooney TP, Thurlbeck WM. The radial alveolar count method of Emery and Mithal: a reappraisal 2-intrauterine and early postnatal lung growth. Thorax 1982;37:580-583.
19. McDonald JW, Pilgram TK. Nuclear expression of p53, p21 and cyclin D1 is increased in bronchioloalveolar carcinoma. Histopathology 1999;34:439-446.
20. Park HS, Park JW, Kim HJ, Choi CW, Lee HJ, Kim BI, Chun YS. Sildenafil alleviates bronchopulmonary dysplasia in neonatal rats by activating the hypoxia-inducible factor signaling pathway. Am J Respir Cell Mol Biol 2013;48:105-113.
21. Belcastro R, Lopez L, Li J, Masood A, Tanswell AK. Chronic lung injury in the neonatal rat: Up-regulation of TGFbeta1 and nitration of IGF-R1 by peroxynitrite as likely contributors to impaired alveologenesis. Free Radic Biol Med 2014;80C:1-11.
22. Chang M, Bany-Mohammed F, Kenney MC, Beharry KD. Effects of a superoxide dismutase mimetic on biomarkers of lung angiogenesis and alveolarization during hyperoxia with intermittent hypoxia. Am J Transl Res 2013;5:594-607.
23. Mandell E, Seedorf G, Gien J, Abman SH. Vitamin D treatment improves survival and infant lung structure after intraamniotic endotoxin exposure in rats: potential role for the prevention of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2014;306:L420-428.
24. Chuang CY, Chen TL, Cherng YG, Tai YT, Chen TG, Chen RM. Lipopolysaccharide induces apoptotic insults to human alveolar epithelial A549 cells through reactive oxygen species-mediated activation of an intrinsic mitochondrion-dependent pathway. Arch Toxicol 2011;85:209-218.
25. Li B, Dong C, Wang G, Zheng H, Wang X, Bai C. Pulmonary epithelial CCR3 promotes LPS-induced lung inflammation by mediating release of IL-8. J Cell Physiol 2011;226:2398-2405.
26. Zhang A, Yan X, Li H, Gu Z, Zhang P, Zhang H, et al. TMEM16A protein attenuates lipopolysaccharide-mediated inflammatory response of human lung epithelial cell line A549. Exp Lung Res 2014;40:237-250.
27. Yamada T, Suzuki E, Gejyo F, Ushiki T. Developmental changes in the structure of the rat fetal lung, with special reference to the airway smooth muscle and vasculature. Arch Histol Cytol 2002;65:55-69.
28. Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 2007;13:688-694.
29. Rogers S, Witz G, Anwar M, Hiatt M, Hegyi T. Antioxidant capacity and oxygen radical diseases in the preterm newborn. Arch Pediatr Adolesc Med 2000;154:544-548.
30. Huang T, Wang W, Tu C, Yang Z, Bramwell D, Sun X. Hydrogen-rich saline attenuates ischemia-reperfusion injury in skeletal muscle. J Surg Res 2015;194:471-480.
31. Miller JD, Benjamin JT, Kelly DR, Frank DB, Prince LS. Chorioamnionitis stimulates angiogenesis in saccular stage fetal lungs via CC chemokines. Am J Physiol Lung Cell Mol Physiol 2010;298:L637-645.
32. Shi J, Yao F, Zhong C, Pan X, Yang Y, Lin Q. Hydrogen saline is protective for acute lung ischaemia/reperfusion injuries in rats. Heart Lung Circ 2012;21:556-563.
33. Perrone S, Tataranno ML, Buonocore G. Oxidative Stress and Bronchopulmonary Dysplasia. J Clin Neonatol 2012;1:109-114.
34. Speer CP. Inflammation and bronchopulmonary dysplasia: a continuing story. Semin Fetal Neonatal Med 2006;11:354-362.
35. Ohno K, Ito M, Ichihara M. Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases. Oxid Med Cell Longev 2012;2012:1-11.
36. Yang X, Guo L, Sun X, Chen X, Tong X. Protective effects of hydrogen-rich saline in preeclampsia rat model. Placenta 2011;32:681-686.
37. Liu W, Chen O, Chen C, Wu B, Tang J, Zhang JH. Protective effects of hydrogen on fetal brain injury during maternal hypoxia. Acta Neurochir Suppl 2011;111:307-311.